Serum activin A as a prognostic biomarker for community acquired pneumonia

doi:10.12998/wjcc.v12.i22.5016

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 22

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (71)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

HTML

Figures (1-3)

Tables (1-3)

Sum=67

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=1

Aug 6, 2024 (publication date) through Jul 2, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Clin Cases. Aug 6, 2024; 12(22): 5016-5023
Published online Aug 6, 2024. doi: 10.12998/wjcc.v12.i22.5016

Full Size Figure Download Figure

Figure 1 Serum levels of activin A in enrolled individuals. A: Serum activin A level distribution in different multiple groups and healthy volunteers, ^aP < 0.05; B: Serum activin A level distribution in different causative etiologies of community-acquired pneumonia in the study patients.

Citation: Wang YT, Liu Y, Zhou GH, Liu K, Fen Y, Ding H. Serum activin A as a prognostic biomarker for community acquired pneumonia. World J Clin Cases 2024; 12(22): 5016-5023
URL: https://www.wjgnet.com/2307-8960/full/v12/i22/5016.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i22.5016